Diametric Capital, LP

Position in ETON — Eton Pharmaceuticals, Inc.

CIK 1719087 BOSTON, MA

Position in ETON

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,646,256

-$1,226,677 QoQ

Shares Held

73,101

-53.4% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#42

of 163 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names. ETON ranks #3 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	105,781	$8,433,919
2	HROW	Harrow, Inc.	116,908	$4,965,082
3	ETON	Eton Pharmaceuticals, Inc. This page	73,101	$2,646,256
4	ANIP	Ani Pharmaceuticals Inc	26,976	$2,233,073
5	DERM	Journey Medical Corp	295,663	$2,093,294
6	NBIX	Neurocrine Biosciences Inc	7,486	$1,261,690
7	LNTH	Lantheus Holdings, Inc.	1,972	$218,773

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,646,256	73,101	-53.4%	Shares	Defined	2026-08-14
2026-03-31	$3,872,933	156,926	-18.8%	Shares	Defined	2026-05-15
2025-12-31	$3,266,251	193,155	+94.5%	Shares	Defined	2026-02-13
2025-09-30	$2,157,984	99,309	+17.0%	Shares	Defined	2025-11-13
2025-06-30	$1,209,226	84,858	+333.0%	Shares	Defined	2025-08-13
2025-03-31	$254,369	19,597	-60.4%	Shares	Defined	2025-05-14
2021-03-31	$362,603	49,536	-4.1%	Shares	Defined	2021-05-17
2020-12-31	$419,776	51,633	+65.8%	Shares	Defined	2021-02-16
2020-09-30	$246,077	31,149	-86.4%	Shares	Defined	2020-11-13
2020-06-30	$1,252,513	229,819	-49.2%	Shares	Defined	2020-08-14
2020-03-31	$1,853,622	452,103	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.